Showing results (261-270 of 363) with videos related to

Sort By:
Pageof 37
Surgery|May 20, 1999
Antiangiogenic therapy of human esophageal cancers with thalidomide in nude miceT Kotoh, D K Dhar, R Masunaga, et al.
Japanese Journal of Clinical Oncology|December 1, 1996
Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagusS Kinugasa, M Tachibana, Y Hishikawa, et al.
The Journal of Surgical Research|January 8, 1999
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomachH Kubota, H Tabara, T Kotoh, et al.
Oncology|July 15, 2000
Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patientsD K Dhar, H Kubota, M Tachibana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in ratsS Maruyama, N Nagasue, D K Dhar, et al.
American Journal of Surgery|September 29, 2004
En-bloc esophagectomy for esophageal cancerMitsuo Tachibana, Shoichi Kinugasa, Hiroshi Yoshimura, et al.
American Journal of Surgery|July 1, 1997
Clinicopathological features of superficial squamous cell carcinoma of the esophagusM Tachibana, H Yoshimura, S Kinugasa, et al.
Anticancer Research|April 19, 2000
Relationship between microvessel quantification and inducibility of endogenous tumor necrosis factor in colorectal adenocarcinomaH Yoshimura, A Chikamoto, T Honda, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liverO N El-Assal, A Yamanoi, Y Soda, et al.
Cancer|November 2, 2002
Serum endostatin predicts tumor vascularity in hepatocellular carcinomaDipok Kumar Dhar, Takashi Ono, Akira Yamanoi, et al.
Pageof 37